Display screen with an animated computer icon

- Sanofi
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a first image in a sequence of a display screen with an animated computer icon;

FIG. 2 is a second image in the sequence thereof;

FIG. 3 is a third image in the sequence thereof;

FIG. 4 is a fourth image in the sequence thereof;

FIG. 5 is a fifth image in the sequence thereof;

FIG. 6 is a sixth image in the sequence thereof;

FIG. 7 is a seventh image in the sequence thereof;

FIG. 8 is a eighth image in the sequence thereof; and,

FIG. 9 is a ninth image in the sequence thereof.

In FIGS. 1-9, the outermost broken line illustrates a display screen with a graphical user interface, and the remaining broken lines illustrate a display screen portion and portions of the graphical user interface. None of the broken lines form part of the claimed design.

The appearance of the display screen with an animated computer icon sequentially transitions between the images shown in FIGS. 1-9. The process or period in which one image transitions to another forms no part of the claimed design.

Claims

The ornamental design for a display screen with an animated computer icon, as shown and described.

Referenced Cited
U.S. Patent Documents
D789963 June 20, 2017 Agashiwala
D823866 July 24, 2018 Laing
D835132 December 4, 2018 Ito
D836123 December 18, 2018 Pillalamarri
D867384 November 19, 2019 Siccardi
D869495 December 10, 2019 Pillalamarri et al.
D887426 June 16, 2020 Matsushita
D894960 September 1, 2020 Levy
D917529 April 27, 2021 Birolo et al.
D917564 April 27, 2021 Indorf et al.
D921654 June 8, 2021 Burnett
D922424 June 15, 2021 Frueh et al.
D922425 June 15, 2021 Frueh
D926207 July 27, 2021 Zheng et al.
D926208 July 27, 2021 Zheng et al.
D928188 August 17, 2021 Giannino
D939548 December 28, 2021 Miyai
20200030044 January 30, 2020 Wang
20220078339 March 10, 2022 Yang
20220203023 June 30, 2022 O'Connor et al.
20220406017 December 22, 2022 Wang et al.
20230395223 December 7, 2023 Lauritzen et al.
Foreign Patent Documents
306514775 April 2021 CN
308567241 April 2024 CN
308849484 September 2024 CN
006794376-0006 September 2019 EM
6277638 May 2024 GB
204247-0001 April 2020 TW
Other references
  • MyWay—Patient Support, posted date unavailable [online], [retrieved Jul. 18, 2024]. Retrieved from internet, https://play.google.com/store/apps/details?id=com.sanofi.us.dupiapp.pro&hl=en_US. (Year: 2024).
  • These highlights do not include all the information needed . . . , posted date unavailable [online], [retrieved Jul. 18, 2024]. Retrieved from internet, https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=93a193ab-9f96-4da6-aa7c-31212e81879a&type=display. (Year: 2024).
  • How to Inject a Pre-Filled Syringe | DUPIXENT® (dupilumab), posted date unavailable [online], [retrieved Jul. 18, 2024]. Retrieved from internet, https://www.dupixent.com/taking-dupixent/prefilled-syringe. (Year: 2024).
  • Notice : Information De L'Utilisateur, posted date unavailable [online], [retrieved Jul. 18, 2024]. Retrieved from internet, https://ansm.sante.fr/uploads/2022/09/12/20220912-aap-lu-psma617-notice.pdf. (Year: 2024).
  • intakeq.com [online], “Body Map / Drawing Questions—IntakeQ & PracticeQ Guides,” posted date unavailable, retrieved on Oct. 23, 2024, retrieved from URL <https://support.intakeq.com/article/49-drawing-questions>, 1 page.
  • researchgate.net [online], “Body map. Head (area 1,2, 23, or 24); neck (area 3 or 25), shoulders . . . ,” posted date unavailable, retrieved on Oct. 23, 2024, retrieved from URL <https://www.researchgate.net/figure/Body-map-Head-area-1-2-23-or-24-neck-area-3-or-25-shoulders-area-4-5-26_fig2_282346406>, 1 page.
  • weareoncare.com [online], “Body map—report and track injuries, skin condition, and client rehabilitation: OnCare,” posted date unavailable, retrieved on Oct. 23, 2024, retrieved from URL <https://www.weareoncare.com/body-map/>, 1 page.
Patent History
Patent number: D1077855
Type: Grant
Filed: Oct 24, 2022
Date of Patent: Jun 3, 2025
Assignee: Sanofi (Paris)
Inventors: Jesse Alvarez (Cambridge, MA), Sylvia Park-Ekecs (Bridgewater Township, NJ), Marina Talavera Flores (Barcelona)
Primary Examiner: Cary M Robinson
Assistant Examiner: Michelle Devlin
Application Number: 29/867,422
Classifications
Current U.S. Class: Humanoid (D14/495)